Psychedelics


The Politics of Grief During a Pandemic


The grief we live with during the COVID-19 pandemic is political.

MindMed’s CEO Jamon “JR” Rahn Wants Nothing To Do With Those Psychedelic Decrim People


"I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes."

Field Trip Announces “World’s First” Virtual Psychedelic Therapy, But Forgets To Mention They Aren’t the First and No Psychedelics Are Involved


Field Trip Ventures leads the charge to use “psychedelic” as a marketing buzzword for any kind of niche therapy.

Bicycle Day 2020 Was Truly Historic, But Not for the Reasons You Think


Jamon A. Rahn, CEO of psychedelic pharmaceutical startup MindMed, offered a glimpse of the future of psychedelic science, including proprietary data and hints of an “LSD neutralizer.”

Psychedelic Video Museum Celebrates Virtual Launch


Contributors to the Daily Psychedelic Video platform gather on Zoom to bless the opening of the Psychedelic Video Museum: a collection of ten years’ worth of their shared visions.

How psychedelic clinical trials are being affected by coronavirus


Almost all clinical psychedelic drug research is being affected in some way or another by COVID-19. But, response measures vary from one organization to the next.

Amidst Pandemic, Psychedelic Investor Christian Angermayer Can’t Imagine Life Beyond Capitalism


As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”

“Flattening The Curve is Complete BS”: Pandemic Advice From Psychedelic Investor Christian Angermayer


In response to the coronavirus pandemic, Christian Angermayer—the world's largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences—dismisses medical experts in his desperation to reboot the economy.

Dear Psychedelic Researchers


The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.

Ayahuasca Healings’ Trinity de Guzman calls coronavirus “a necessary purge”


“The Corona Virus is a necessary purge of what is no longer in resonance,” Trinity de Guzman wrote in a recent email to his followers.

Native American Churches Request that Peyote Not Be Included in Decriminalization Initiatives


A long-fought battle for access to peyote, and a dwindling population in the United States has led Native American Church members and peyote conservationists to request that peyote be left out of decriminalization efforts.

Calm Down. What’s the Worst Thing That the Wellness Industry Could Do to Psychedelics?


As technology and psychedelics turn to mental health, we’ll likely see a future where we are treated based on our digital biomarkers, and sold mental health services based on the personal data we surrender.

Talking Psychedelic Capitalism in a WeWork Ballroom


Psychedelic capitalists justify their decision to go for-profit in the ballroom of America’s most recent for-profit flop.

Christian Angermayer’s ATAI Life Sciences is positioned to take the psychedelic throne from MAPS


After decades of psychedelic nonprofits paving regulatory pathways and priming wealthy investors, for-profits are moving in to reap the rewards.

“Making psychedelics boring again”— Unless you’re a privileged psychedelic executive, of course


The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.

Psychedelic Trade Secrets and Get-Rich-Quick Schemes —a Benefit to Investors, a Harm to Progress


“Play the field right and there’s money to be made even off some of the shit companies purely based on the wave.”

Never Forget: Before There Was A Mush Rush, There Was A Plea For Decency


Many predicted an ethical storm brewing in the lead-up to the explosion of for-profit interest in psychedelic pharmaceuticals. But, were their efforts to mitigate the damage enough to make a difference?

Psychedelics for Climate Action?


Can psychedelic civil disobedience really stimulate systemic reorganization?

Eleusis Benefit Corp: Taking the “Psychedelic” Out of Psychedelics


Shlomi Raz, CEO of Eleusis Benefit Corporation, made false claims about psychedelics. We asked multiple ethnobotanists, a medical anthropologist, and a chemist if they could help us set the record straight.

Psychedelics


The Politics of Grief During a Pandemic


The grief we live with during the COVID-19 pandemic is political.

MindMed’s CEO Jamon “JR” Rahn Wants Nothing To Do With Those Psychedelic Decrim People


"I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes."

Field Trip Announces “World’s First” Virtual Psychedelic Therapy, But Forgets To Mention They Aren’t the First and No Psychedelics Are Involved


Field Trip Ventures leads the charge to use “psychedelic” as a marketing buzzword for any kind of niche therapy.

Bicycle Day 2020 Was Truly Historic, But Not for the Reasons You Think


Jamon A. Rahn, CEO of psychedelic pharmaceutical startup MindMed, offered a glimpse of the future of psychedelic science, including proprietary data and hints of an “LSD neutralizer.”

Psychedelic Video Museum Celebrates Virtual Launch


Contributors to the Daily Psychedelic Video platform gather on Zoom to bless the opening of the Psychedelic Video Museum: a collection of ten years’ worth of their shared visions.

How psychedelic clinical trials are being affected by coronavirus


Almost all clinical psychedelic drug research is being affected in some way or another by COVID-19. But, response measures vary from one organization to the next.

Amidst Pandemic, Psychedelic Investor Christian Angermayer Can’t Imagine Life Beyond Capitalism


As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”

“Flattening The Curve is Complete BS”: Pandemic Advice From Psychedelic Investor Christian Angermayer


In response to the coronavirus pandemic, Christian Angermayer—the world's largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences—dismisses medical experts in his desperation to reboot the economy.

Dear Psychedelic Researchers


The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.

Ayahuasca Healings’ Trinity de Guzman calls coronavirus “a necessary purge”


“The Corona Virus is a necessary purge of what is no longer in resonance,” Trinity de Guzman wrote in a recent email to his followers.

Native American Churches Request that Peyote Not Be Included in Decriminalization Initiatives


A long-fought battle for access to peyote, and a dwindling population in the United States has led Native American Church members and peyote conservationists to request that peyote be left out of decriminalization efforts.

Calm Down. What’s the Worst Thing That the Wellness Industry Could Do to Psychedelics?


As technology and psychedelics turn to mental health, we’ll likely see a future where we are treated based on our digital biomarkers, and sold mental health services based on the personal data we surrender.

Talking Psychedelic Capitalism in a WeWork Ballroom


Psychedelic capitalists justify their decision to go for-profit in the ballroom of America’s most recent for-profit flop.

Christian Angermayer’s ATAI Life Sciences is positioned to take the psychedelic throne from MAPS


After decades of psychedelic nonprofits paving regulatory pathways and priming wealthy investors, for-profits are moving in to reap the rewards.

“Making psychedelics boring again”— Unless you’re a privileged psychedelic executive, of course


The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.

Psychedelic Trade Secrets and Get-Rich-Quick Schemes —a Benefit to Investors, a Harm to Progress


“Play the field right and there’s money to be made even off some of the shit companies purely based on the wave.”

Never Forget: Before There Was A Mush Rush, There Was A Plea For Decency


Many predicted an ethical storm brewing in the lead-up to the explosion of for-profit interest in psychedelic pharmaceuticals. But, were their efforts to mitigate the damage enough to make a difference?

Psychedelics for Climate Action?


Can psychedelic civil disobedience really stimulate systemic reorganization?

Eleusis Benefit Corp: Taking the “Psychedelic” Out of Psychedelics


Shlomi Raz, CEO of Eleusis Benefit Corporation, made false claims about psychedelics. We asked multiple ethnobotanists, a medical anthropologist, and a chemist if they could help us set the record straight.